RXL:ARCA-ProShares Ultra Health Care

ETF | Others | NYSE Arca

Last Closing

USD 105

Change

+0.49 (+0.47)%

Market Cap

USD 0.07B

Volume

9.80K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Health CareSM Index. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index measures the performance of the healthcare sector of the U.S. equity market. Component companies include, among others, health care providers, biotechnology companies, medical supplies, advanced medical devices and pharmaceuticals. The fund is non-diversified.

Inception Date: 30/01/2007

Primary Benchmark: DJ US Health Care TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.06%

Management Expense Ratio: 0.95 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-07-15 )

Largest Industry Peers for Others

Symbol Name Mer Price(Change) Market Cap
SOJE SOJE 0.00 %

+0.70 (+3.66%)

USD 65.72B
JEPI JPMorgan Equity Premium Income.. 0.00 %

+0.44 (+0.79%)

USD 32.43B
DTB DTB 0.00 %

+1.19 (+6.19%)

USD 26.58B
DFAC Dimensional U.S. Core Equity 2.. 0.00 %

+0.36 (+1.19%)

USD 26.00B
GBTC Grayscale Bitcoin Trust (BTC) 0.00 %

-0.05 (-0.08%)

USD 23.75B
JPST JPMorgan Ultra-Short Income ET.. 0.00 %

+0.02 (+0.04%)

USD 22.73B
SGOV iShares® 0-3 Month Treasury B.. 0.00 %

+0.01 (+0.01%)

USD 19.79B
AVUV Avantis® U.S. Small Cap Value.. 0.00 %

+1.53 (+1.72%)

USD 10.49B
DFUV Dimensional US Marketwide Valu.. 0.00 %

+0.37 (+0.94%)

USD 10.15B
DFAT Dimensional U.S. Targeted Valu.. 0.00 %

+0.59 (+1.15%)

USD 9.40B

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
EUSC WisdomTree Europe Hedged .. 2.32 % 0.58 %

+0.27 (+0.91%)

USD 0.04B
SMCX:SW SPDR® MSCI Europe Small .. 0.49 % 0.00 %

+2.60 (+0.91%)

USD 0.22B
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

+0.87 (+0.91%)

USD 0.12B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

+0.49 (+0.91%)

USD 9.99B
XXSC:LSE db x-trackers MSCI Europe.. 0.00 % 0.00 %

+46.50 (+0.91%)

USD 1.10B
MMS:PA Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

+5.33 (+0.91%)

USD 0.27B
SMC:PA SPDR MSCI Europe Small Ca.. 0.00 % 0.00 %

+3.70 (+0.91%)

USD 0.22B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

+2.70 (+0.91%)

USD 0.29B
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

+0.36 (+0.91%)

USD 0.17B
LGWU:XETRA Amundi MSCI EMU Small Cap.. 0.00 % 0.00 %

+3.90 (+0.91%)

USD 0.27B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

+0.37 (+0.91%)

USD 0.17B
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.49% 64% D 58% F
Dividend Return 0.23% 4% F 3% F
Total Return 15.71% 60% D- 54% F
Trailing 12 Months  
Capital Gain 6.09% 78% C+ 71% C-
Dividend Return 0.39% 6% D- 4% F
Total Return 6.48% 71% C- 63% D
Trailing 5 Years  
Capital Gain 112.95% 96% N/A 92% A
Dividend Return 2.72% 15% F 10% F
Total Return 115.67% 96% N/A 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 15.14% 72% C 73% C
Dividend Return 15.50% 67% D+ 71% C-
Total Return 0.37% 39% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 20.01% 76% C+ 63% D
Risk Adjusted Return 77.49% 87% B+ 87% B+
Market Capitalization 0.07B 51% F 24% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.